Home/VenoStent/Tim Boire, PhD
TB

Tim Boire, PhD

CEO & Co-founder

VenoStent

Therapeutic Areas

VenoStent Pipeline

DrugIndicationPhase
SelfWrapImprovement of arteriovenous (AV) access site maturation and patency for hemodialysisPivotal Trial